Viewing Study NCT02722694


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-04-23 @ 10:13 PM
Study NCT ID: NCT02722694
Status: UNKNOWN
Last Update Posted: 2016-09-13
First Post: 2016-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 3 Study of Abatacept in Chinese Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module